# Esco Technologies Inc: financial statements, quarterly

ESE · NYSE · CIK 866706 · [Technology](/sectors/technology.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/ese.md) · [Financials](/companies/ese/financials.md) · [Filings](/companies/ese/filings.md) · [Insiders](/companies/ese/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ese/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [172 d](/filings/0001104659-25-117276.md) | [218](/filings/0001410578-25-000100.md) | [249](/filings/0001410578-25-001145.md) | [234](/filings/0001410578-25-001667.md) | [274 d](/filings/0001104659-25-117276.md) | [215](/filings/0001104659-26-011932.md) | [232](/filings/0001104659-26-058482.md) | [296](/filings/0001104659-26-093266.md) | [353 d](/filings/0001104659-25-117276.md) | [290](/filings/0001104659-26-011932.md) | [309](/filings/0001104659-26-058482.md) | [339](/filings/0001104659-26-093266.md) |
| Cost of revenue | $m | [86.7 d](/filings/0001104659-25-117276.md) | [134](/filings/0001410578-25-000100.md) | [152](/filings/0001410578-25-001145.md) | [135](/filings/0001410578-25-001667.md) | [152 d](/filings/0001104659-25-117276.md) | [124](/filings/0001104659-26-011932.md) | [133](/filings/0001104659-26-058482.md) | [174](/filings/0001104659-26-093266.md) | [203 d](/filings/0001104659-25-117276.md) | [170](/filings/0001104659-26-011932.md) | [178](/filings/0001104659-26-058482.md) | [198](/filings/0001104659-26-093266.md) |
| Selling, general and administrative | $m | [42.9 d](/filings/0001104659-25-117276.md) | [54.0](/filings/0001410578-25-000100.md) | [55.1](/filings/0001410578-25-001145.md) | [51.0](/filings/0001410578-25-001667.md) | [55.6 d](/filings/0001104659-25-117276.md) | [55.0](/filings/0001104659-26-011932.md) | [54.3](/filings/0001104659-26-058482.md) | [62.0](/filings/0001104659-26-093266.md) | [63.3 d](/filings/0001104659-25-117276.md) | [61.2](/filings/0001104659-26-011932.md) | [62.8](/filings/0001104659-26-058482.md) | [71.0](/filings/0001104659-26-093266.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | [28.1](/filings/0001104659-26-011932.md) | not reported | not reported | not reported | [38.4](/filings/0001104659-26-011932.md) | not reported | not reported |
| Interest expense | $m | [2.3 d](/filings/0001104659-25-117276.md) | [2.7](/filings/0001410578-25-000100.md) | [3.2](/filings/0001410578-25-001145.md) | [3.3](/filings/0001410578-25-001667.md) | [6.0 d](/filings/0001104659-25-117276.md) | [2.3](/filings/0001104659-26-011932.md) | [2.2](/filings/0001410578-25-001145.md) | [7.9](/filings/0001410578-25-001667.md) | [5.1 d](/filings/0001104659-25-117276.md) | [2.9](/filings/0001104659-26-011932.md) | not reported | not reported |
| Income tax | $m | [7.5 d](/filings/0001104659-25-117276.md) | [4.3](/filings/0001410578-25-000100.md) | [6.0](/filings/0001410578-25-001145.md) | [7.7](/filings/0001410578-25-001667.md) | [11.3 d](/filings/0001104659-25-117276.md) | [5.5](/filings/0001104659-26-011932.md) | [8.0](/filings/0001104659-26-058482.md) | [8.3](/filings/0001104659-26-093266.md) | [14.7 d](/filings/0001104659-25-117276.md) | [6.8](/filings/0001104659-26-011932.md) | [10.3](/filings/0001104659-26-058482.md) | [8.2](/filings/0001104659-26-093266.md) |
| Net income | $m | [32.0 d](/filings/0001104659-25-117276.md) | [15.2](/filings/0001410578-25-000100.md) | [23.2](/filings/0001410578-25-001145.md) | [29.2](/filings/0001410578-25-001667.md) | [34.3 d](/filings/0001104659-25-117276.md) | [23.5](/filings/0001104659-26-011932.md) | [31.0](/filings/0001104659-26-058482.md) | [26.1](/filings/0001104659-26-093266.md) | [219 d](/filings/0001104659-25-117276.md) | [28.7](/filings/0001104659-26-011932.md) | [34.7](/filings/0001104659-26-058482.md) | [32.7](/filings/0001104659-26-093266.md) |
| Diluted EPS | $ per share | not reported | [0.59](/filings/0001410578-25-000100.md) | [0.90](/filings/0001410578-25-001145.md) | [1.13](/filings/0001410578-25-001667.md) | not reported | [0.91](/filings/0001104659-26-011932.md) | [1.20](/filings/0001104659-26-058482.md) | [1.01](/filings/0001104659-26-093266.md) | not reported | [1.11](/filings/0001104659-26-011932.md) | [1.34](/filings/0001104659-26-058482.md) | [1.26](/filings/0001104659-26-093266.md) |
| Basic EPS | $ per share | not reported | [0.59](/filings/0001410578-25-000100.md) | [0.90](/filings/0001410578-25-001145.md) | [1.14](/filings/0001410578-25-001667.md) | not reported | [0.91](/filings/0001104659-26-011932.md) | [1.20](/filings/0001104659-26-058482.md) | [1.01](/filings/0001104659-26-093266.md) | not reported | [1.11](/filings/0001104659-26-011932.md) | [1.34](/filings/0001104659-26-058482.md) | [1.26](/filings/0001104659-26-093266.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [41.9](/filings/0001410578-24-002064.md) | [51.4](/filings/0001410578-24-000030.md) | [59.4](/filings/0001410578-24-000723.md) | [63.0](/filings/0001410578-24-001264.md) | [66.0](/filings/0001104659-25-117276.md) | [71.3](/filings/0001410578-25-000100.md) | [57.4](/filings/0001410578-25-001145.md) | [78.7](/filings/0001410578-25-001667.md) | [101](/filings/0001104659-26-093266.md) | [104](/filings/0001104659-26-011932.md) | [92.3](/filings/0001104659-26-058482.md) | [73.2](/filings/0001104659-26-093266.md) |
| Current assets | $m | [581](/filings/0001410578-24-002064.md) | [603](/filings/0001410578-24-000030.md) | [622](/filings/0001410578-24-000723.md) | [653](/filings/0001410578-24-001264.md) | [669](/filings/0001104659-25-117276.md) | [646](/filings/0001410578-25-000100.md) | [661](/filings/0001410578-25-001145.md) | [755](/filings/0001410578-25-001667.md) | [689](/filings/0001104659-26-093266.md) | [690](/filings/0001104659-26-011932.md) | [727](/filings/0001104659-26-058482.md) | [756](/filings/0001104659-26-093266.md) |
| Total assets | $m | [1,683](/filings/0001410578-24-002064.md) | [1,773](/filings/0001410578-24-000030.md) | [1,784](/filings/0001410578-24-000723.md) | [1,811](/filings/0001410578-24-001264.md) | [1,839](/filings/0001104659-25-117276.md) | [1,795](/filings/0001410578-25-000100.md) | [1,696](/filings/0001104659-26-058482.md) | [2,415](/filings/0001104659-26-093266.md) | [2,410](/filings/0001104659-26-093266.md) | [2,399](/filings/0001104659-26-011932.md) | [2,406](/filings/0001104659-26-058482.md) | [2,420](/filings/0001104659-26-093266.md) |
| Current liabilities | $m | [315](/filings/0001410578-24-002064.md) | [305](/filings/0001410578-24-000030.md) | [289](/filings/0001410578-24-000723.md) | [311](/filings/0001410578-24-001264.md) | [350](/filings/0001104659-25-117276.md) | [316](/filings/0001410578-25-000100.md) | [322](/filings/0001410578-25-001145.md) | [497](/filings/0001410578-25-001667.md) | [508](/filings/0001104659-26-093266.md) | [518](/filings/0001104659-26-011932.md) | [500](/filings/0001104659-26-058482.md) | [547](/filings/0001104659-26-093266.md) |
| Total liabilities | $m | [552](/filings/0001410578-24-002064.md) | [618](/filings/0001410578-24-000030.md) | [618](/filings/0001410578-24-000723.md) | [617](/filings/0001410578-24-001264.md) | [601](/filings/0001104659-25-117276.md) | [558](/filings/0001410578-25-000100.md) | [538](/filings/0001410578-25-001145.md) | [1,200](/filings/0001410578-25-001667.md) | [870](/filings/0001104659-26-093266.md) | [838](/filings/0001104659-26-011932.md) | [820](/filings/0001104659-26-058482.md) | [803](/filings/0001104659-26-093266.md) |
| Long-term debt | $m | [82.0](/filings/0001410578-24-002064.md) | [152](/filings/0001410578-24-000030.md) | [171](/filings/0001410578-24-000723.md) | [153](/filings/0001410578-24-001264.md) | [102](/filings/0001104659-25-117276.md) | [92.0](/filings/0001410578-25-000100.md) | [68.0](/filings/0001410578-25-001145.md) | [505](/filings/0001410578-25-001667.md) | [166](/filings/0001104659-26-093266.md) | [125](/filings/0001104659-26-011932.md) | [125](/filings/0001104659-26-058482.md) | [65.0](/filings/0001104659-26-093266.md) |
| Current portion of debt | $m | [20.0](/filings/0001410578-23-002596.md) | [20.0](/filings/0001410578-24-000030.md) | [20.0](/filings/0001410578-24-000723.md) | [20.0](/filings/0001410578-24-001264.md) | [20.0](/filings/0001410578-24-002064.md) | [20.0](/filings/0001410578-25-000100.md) | [20.0](/filings/0001410578-25-001145.md) | [20.0](/filings/0001410578-25-001667.md) | [20.0](/filings/0001104659-26-093266.md) | [20.0](/filings/0001104659-26-011932.md) | [20.0](/filings/0001104659-26-058482.md) | [20.0](/filings/0001104659-26-093266.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,131](/filings/0001104659-25-117276.md) | [1,154](/filings/0001410578-25-000100.md) | [1,166](/filings/0001410578-25-001145.md) | [1,194](/filings/0001410578-25-001667.md) | [1,237](/filings/0001104659-25-117276.md) | [1,237](/filings/0001104659-26-011932.md) | [1,277](/filings/0001104659-26-058482.md) | [1,327](/filings/0001104659-26-093266.md) | [1,541](/filings/0001104659-26-093266.md) | [1,561](/filings/0001104659-26-011932.md) | [1,585](/filings/0001104659-26-058482.md) | [1,617](/filings/0001104659-26-093266.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent, us-gaap:DebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [47.7 d](/filings/0001104659-25-117276.md) | [8.7](/filings/0001410578-25-000100.md) | [10.5 d](/filings/0001410578-25-001145.md) | [36.2 d](/filings/0001410578-25-001667.md) | [72.1 d](/filings/0001104659-25-117276.md) | [34.2](/filings/0001104659-26-011932.md) | [24.1 d](/filings/0001104659-26-058482.md) | [73.7 d](/filings/0001104659-26-093266.md) | [110 d](/filings/0001104659-25-117276.md) | [68.9](/filings/0001104659-26-011932.md) | [6.4 d](/filings/0001104659-26-058482.md) | [58.8 d](/filings/0001104659-26-093266.md) |
| Capital expenditure | $m | [2.7 d](/filings/0001104659-25-117276.md) | [7.8](/filings/0001410578-25-000100.md) | [8.5 d](/filings/0001410578-25-001145.md) | [3.3 d](/filings/0001410578-25-001667.md) | [8.7 d](/filings/0001104659-25-117276.md) | [5.1](/filings/0001104659-26-011932.md) | [9.7 d](/filings/0001104659-26-058482.md) | [9.3 d](/filings/0001104659-26-093266.md) | [12.1 d](/filings/0001104659-25-117276.md) | [5.9](/filings/0001104659-26-011932.md) | [7.2 d](/filings/0001104659-26-058482.md) | [11.4 d](/filings/0001104659-26-093266.md) |
| Dividends paid | $m | [2.1 d](/filings/0001104659-25-117276.md) | [2.1](/filings/0001410578-25-000100.md) | [2.1 d](/filings/0001410578-25-001145.md) | [2.1 d](/filings/0001410578-25-001667.md) | [2.1 d](/filings/0001104659-25-117276.md) | [2.1](/filings/0001104659-26-011932.md) | [2.1 d](/filings/0001104659-26-058482.md) | [2.1 d](/filings/0001104659-26-093266.md) | [2.1 d](/filings/0001104659-25-117276.md) | [2.1](/filings/0001104659-26-011932.md) | [2.1 d](/filings/0001104659-26-058482.md) | [2.1 d](/filings/0001104659-26-093266.md) |
| Share repurchases | $m | [0.0 d](/filings/0001104659-25-117276.md) | [2.1](/filings/0001410578-24-000030.md) | [5.1 d](/filings/0001410578-25-001145.md) | [0.8 d](/filings/0001410578-25-001667.md) | [0.0 d](/filings/0001104659-25-117276.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [25.9](/filings/0001410578-24-000030.md) | [25.9](/filings/0001410578-24-000723.md) | [25.8](/filings/0001410578-24-001264.md) | [25.8](/filings/0001410578-25-000100.md) | [25.8](/filings/0001410578-25-001145.md) | [25.8](/filings/0001410578-25-001667.md) | [25.8](/filings/0001104659-26-011932.md) | [25.9](/filings/0001104659-26-058482.md) | [25.9](/filings/0001104659-26-093266.md) | [25.9](/filings/0001104659-26-011932.md) | [25.9](/filings/0001104659-26-058482.md) | [26.0](/filings/0001104659-26-093266.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 25,907,567 at 2026-07-31, from the cover of the [10-Q filed 2026-08-10](/filings/0001104659-26-093266.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.